P
PHARMA
vs
COR
COR
Over the past 12 months, PHARMA has significantly outperformed COR, delivering a return of +63% compared to the COR's +30% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
COR
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
P
|
Pharmaniaga Bhd
KLSE:PHARMA
|
0.325
MYR
|
|||||
|
Cencora Inc
NYSE:COR
|
329.15
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
PHARMA, COR
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
P
|
Pharmaniaga Bhd
Revenue
|
|||||||||||
|
|
Cencora Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
PHARMA, COR
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
P
|
Pharmaniaga Bhd
KLSE:PHARMA
|
|||||||||
|
|
Cencora Inc
NYSE:COR
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
PHARMA, COR
Performance By Year
PHARMA, COR
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
